China Medical System Holdings (CMS) has expanded its partnership with Insilico Medicine in an AI-powered drug discovery collaboration valued at up to $177 million. The agreement focuses on a mass-mark
MindRank AI, a clinical-stage biotechnology firm, has successfully raised $52 million in Series B funding. This capital infusion will be utilized to further develop its proprietary Molecule Arts Platf
Artificial intelligence is no longer a future concept in life sciences, but is actively transforming pharmaceutical research and development (R&D) by compressing discovery timelines and enabling high-
Chai Discovery has announced a collaboration with Novartis to advance AI-driven antibody discovery, building on previous agreements with Pfizer and Eli Lilly. The partnership aims to leverage Chai's A
A collaborative research team from KAIST, Sungkyunkwan University, and Korea University Anam Hospital has developed an AI technology capable of detecting early warning signs of cerebrovascular disease
The Israel Innovation Authority announced a NIS 70 million investment (approximately $23.2 million USD) to establish the Israel BioToken Factory Initiative (IBFI). This national R&D consortium aims to